GEMMA, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 3.604
AS - Asia 1.655
EU - Europa 1.646
SA - Sud America 264
Continente sconosciuto - Info sul continente non disponibili 214
AF - Africa 58
OC - Oceania 6
Totale 7.447
Nazione #
US - Stati Uniti d'America 3.367
SG - Singapore 608
CN - Cina 369
IT - Italia 361
DE - Germania 260
RU - Federazione Russa 228
SE - Svezia 218
CA - Canada 211
BR - Brasile 200
VN - Vietnam 196
HK - Hong Kong 190
IE - Irlanda 150
UA - Ucraina 100
GB - Regno Unito 86
IN - India 86
FR - Francia 68
DK - Danimarca 41
FI - Finlandia 33
BD - Bangladesh 31
TR - Turchia 25
IQ - Iraq 22
NL - Olanda 22
AR - Argentina 21
MX - Messico 18
ZA - Sudafrica 18
BE - Belgio 17
ES - Italia 16
KR - Corea 16
SA - Arabia Saudita 15
ID - Indonesia 13
CO - Colombia 12
EC - Ecuador 12
JP - Giappone 12
PK - Pakistan 10
PL - Polonia 10
PH - Filippine 9
VE - Venezuela 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
EG - Egitto 6
MY - Malesia 6
UZ - Uzbekistan 6
AT - Austria 5
CL - Cile 5
ET - Etiopia 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
IR - Iran 4
MA - Marocco 4
NP - Nepal 4
TW - Taiwan 4
AU - Australia 3
BG - Bulgaria 3
CH - Svizzera 3
EU - Europa 3
JM - Giamaica 3
KE - Kenya 3
OM - Oman 3
PE - Perù 3
TH - Thailandia 3
BH - Bahrain 2
BO - Bolivia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
LT - Lituania 2
MN - Mongolia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
ZM - Zambia 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
AL - Albania 1
BB - Barbados 1
BF - Burkina Faso 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
KG - Kirghizistan 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
NC - Nuova Caledonia 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
Totale 7.232
Città #
Singapore 338
Ann Arbor 325
Ashburn 317
Woodbridge 279
Fairfield 207
Hong Kong 187
San Jose 187
Chandler 179
Toronto 160
Houston 153
Dublin 143
Frankfurt am Main 130
Wilmington 120
Milan 99
Jacksonville 93
New York 88
Dearborn 75
Cambridge 74
Council Bluffs 71
Seattle 70
Dallas 65
Santa Clara 61
Los Angeles 60
The Dalles 60
Ho Chi Minh City 56
Beijing 53
Princeton 53
Hanoi 44
Chicago 43
Rome 39
Shanghai 33
Nanjing 32
Buffalo 30
Altamura 27
Lauterbourg 25
Lawrence 24
Columbus 22
Orem 22
Lachine 17
Boston 15
Moscow 15
San Diego 15
Helsinki 14
Johannesburg 14
Fremont 13
São Paulo 13
Guangzhou 12
Shenyang 12
Brussels 11
Da Nang 11
Munich 11
Tianjin 11
Dong Ket 10
Haiphong 10
London 9
Seoul 9
Tokyo 9
Brooklyn 8
Hefei 8
Jinan 8
Manchester 8
Mountain View 8
Ottawa 8
Phoenix 8
Valencia 8
Washington 8
Amsterdam 7
Chennai 7
Denver 7
Nanchang 7
Rio de Janeiro 7
Riyadh 7
Warsaw 7
Andover 6
Boardman 6
Charlotte 6
Hangzhou 6
Jiaxing 6
Lissone 6
Mexico City 6
Montreal 6
Paris 6
Tashkent 6
Baghdad 5
Brasília 5
Cairo 5
Changsha 5
Delhi 5
Edmonton 5
Hebei 5
Jakarta 5
Kuala Lumpur 5
Medellín 5
Mumbai 5
Nuremberg 5
Nürnberg 5
Salvador 5
San Francisco 5
Valmadrera 5
Addis Ababa 4
Totale 4.540
Nome #
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 467
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 395
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 370
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 328
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 323
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 312
The impact of liver disease on the health-related quality of life 312
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 309
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 297
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 296
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 294
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 294
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 289
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 287
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 282
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 278
Health Related Quality of Life in the Major Liver Conditions 276
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 273
Feasibility of standard mechanical ventilation with low FiO2 and small endotracheal tubes during laser microlaryngeal surgery 254
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 248
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 245
Distribution of the cortico-spinal fibres in the cervical and lumbar enlargements of the rat spinal cord 240
MortalitY in caRdIAc surgery (MYRIAD): A randomizeD controlled trial of volatile anesthetics. Rationale and design 236
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 221
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 168
Continuous use of neuromuscular relaxants in the management of head injured patients 153
Totale 7.447
Categoria #
all - tutte 23.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.475


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022302 0 28 33 46 3 33 16 32 15 18 17 61
2022/2023685 67 257 46 58 30 89 10 49 37 3 32 7
2023/2024443 17 14 8 38 41 133 88 15 38 5 4 42
2024/20251.002 66 99 96 31 82 31 50 33 145 161 79 129
2025/20262.532 311 104 181 196 274 105 338 98 218 256 282 169
2026/2027149 53 96 0 0 0 0 0 0 0 0 0 0
Totale 7.447